COMPANY

Immusoft Corp.

HQ: Seattle, WA source · immusoft.com ↗ · West Coast

Keywords: protein therapeutics cell therapy rare disease mucopolysaccharidosis rare diseases

Location: Seattle, WA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Timeline

Mar 30, 2026 Grant Government grant: $15M (total, as published), announced Mar 30, 2026. Source: company's own press page. source ↗

Last 2 years.

Mar 30, 2026 Government grant: $15M (total, as published), announced Mar 30, 2026. Source: company's own press page. source ↗

Annual award amounts. Total $4.4M.

Sep 24, 2020 NIH award 1R43NS120264-01A1 FY2020: $466,804 awarded for that fiscal year; activity R43 (SBIR); PI HAMPE, CHRISTIANE S; recipient as written: IMMUSOFT CORPORATION, SEATTLE, WA. Transposon Engineered B Cell Therapy fo source ↗
Aug 16, 2019 NIH award 5R44GM115192-03 FY2019: $2,560,312 awarded for that fiscal year; activity R44 (SBIR); PI HAMPE, CHRISTIANE S; recipient as written: IMMUSOFT CORPORATION, SEATTLE, WA. Sleeping Beauty Engineered B Cells for source ↗
Aug 28, 2018 NIH award 2R44GM115192-02A1 FY2018: $1,028,903 awarded for that fiscal year; activity R44 (SBIR); PI HAMPE, CHRISTIANE S; recipient as written: IMMUSOFT CORPORATION, SEATTLE, WA. Sleeping Beauty Engineered B Cells fo source ↗
Jul 3, 2012 NIH award 1R41AI098603-01 FY2012: $300,000 awarded for that fiscal year; activity R41 (STTR); PI HERBIG, ERIC; recipient as written: IMMUSOFT CORPORATION, SEATTLE, WA. Testing of novel system to deliver VRC01 in mous source ↗